Zhenyuan Dong

915 citations
25 papers · 660 indexed · h-index 12
Topics
CAR-T cell therapy research (10 papers)Influenza Virus Research Studies (7 papers)Respiratory viral infections research (6 papers)
Partner nations
United StatesChinaJapan

In The Last Decade

Zhenyuan Dong

23 papers receiving 652 citations

Peers

Zhenyuan Dong
Comparison fields: 5 of 77
  • Immunology 236
  • Epidemiology 216
  • Molecular Biology 176
  • Oncology 162
  • Physiology 104
Replace Anita Parmigiani with:
Anita Parmigiani United States
L. Terry Spencer United States
Salil Garg United States
Tiffany A. Coon United States
André Bouchot France
Thomas Riffelmacher United Kingdom
Nidhi Kedia-Mehta Ireland
Elizabeth M. Steinert United States
Kristin Lampe United States
Zhenyuan Dong relative to Anita Parmigiani United States Anita Parmigiani's profile →
Citations per field
00.5×3.0×
Anita Parmigiani · 1×
Citations per year

Countries citing papers authored by Zhenyuan Dong

Since Specialization
Citations

This map shows the geographic impact of Zhenyuan Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenyuan Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenyuan Dong more than expected).

Fields of papers citing papers by Zhenyuan Dong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhenyuan Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenyuan Dong. The network helps show where Zhenyuan Dong may publish in the future.

Co-authorship network of co-authors of Zhenyuan Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Zhenyuan Dong. A scholar is included among the top collaborators of Zhenyuan Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhenyuan Dong. Zhenyuan Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 9
3 0
4 8
5 3
6 27
7 3
8 17
9 91
10 26
11 24
12 2
13 89
14 1
15 8
16 13
17 99
18 14
19 4
20
[The antitumor effect of adriamycin conjugated with monoclonal antibody against gastric cancer in vitro and in vivo].
9

About Zhenyuan Dong

Zhenyuan Dong is a scholar working on Oncology, Immunology and Epidemiology, having authored 25 papers that have together received 660 indexed citations. Recurring topics across this work include CAR-T cell therapy research (10 papers), Influenza Virus Research Studies (7 papers) and Respiratory viral infections research (6 papers). The work is most often cited by research in Immunology (236 citations), Biochemistry (54 citations) and Epidemiology (216 citations). Zhenyuan Dong has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Keping Xie, Xufeng Qi, Isaiah J. Fidler, Larry W. Kwak, Chufang Li, Ling Chen, Weiqi Pan, Hong Qin, Caijun Sun and Liqiang Feng. Their work appears in journals such as Nature Communications, Blood and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026